Unknown

Dataset Information

0

Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell-Like Phenotype.


ABSTRACT: Pancreatic cancer remains an incurable condition. Its progression is driven, in part, by subsets of cancer cells that evade the cytotoxic effects of conventional chemotherapies. These cells are often low-cycling, multidrug resistant, and adopt a stem cell-like phenotype consistent with the concept of cancer stem cells (CSC). To identify drugs impacting on tumor-promoting CSCs, we performed a differential high-throughput drug screen in pancreatic cancer cells cultured in traditional (2D) monolayers versus three-dimensional (3D) spheroids which replicate key elements of the CSC model. Among the agents capable of killing cells cultured in both formats was a 1H-benzo[d]imidazol-2-amine-based inhibitor of IL2-inducible T-cell kinase (ITK; NCGC00188382, inhibitor #1) that effectively mediated growth inhibition and induction of apoptosis in vitro, and suppressed cancer progression and metastasis formation in vivo An examination of this agent's polypharmacology via in vitro and in situ phosphoproteomic profiling demonstrated an activity profile enriched for mediators involved in DNA damage repair. Included was a strong inhibitory potential versus the thousand-and-one amino acid kinase 3 (TAOK3), CDK7, and aurora B kinases. We found that cells grown under CSC-enriching spheroid conditions are selectively dependent on TAOK3 signaling. Loss of TAOK3 decreases colony formation, expression of stem cell markers, and sensitizes spheroids to the genotoxic effect of gemcitabine, whereas overexpression of TAOK3 increases stem cell traits including tumor initiation and metastasis formation. By inactivating multiple components of the cell-cycle machinery in concert with the downregulation of key CSC signatures, inhibitor #1 defines a distinctive strategy for targeting pancreatic cancer cell populations.

SUBMITTER: Bian Y 

PROVIDER: S-EPMC6825557 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell-Like Phenotype.

Bian Yansong Y   Teper Yaroslav Y   Mathews Griner Lesley A LA   Aiken Taylor J TJ   Shukla Vivek V   Guha Rajarshi R   Shinn Paul P   Xin Hong-Wu HW   Pflicke Holger H   Powers Astin S AS   Li Dandan D   Jiang Jian-Kang JK   Patel Paresma P   Rogers Steven A SA   Aubé Jeffrey J   Ferrer Marc M   Thomas Craig J CJ   Rudloff Udo U  

Molecular cancer therapeutics 20190808 11


Pancreatic cancer remains an incurable condition. Its progression is driven, in part, by subsets of cancer cells that evade the cytotoxic effects of conventional chemotherapies. These cells are often low-cycling, multidrug resistant, and adopt a stem cell-like phenotype consistent with the concept of cancer stem cells (CSC). To identify drugs impacting on tumor-promoting CSCs, we performed a differential high-throughput drug screen in pancreatic cancer cells cultured in traditional (2D) monolaye  ...[more]

Similar Datasets

2021-03-08 | MSV000087015 | MassIVE
| S-EPMC3206173 | biostudies-other
| S-EPMC6333332 | biostudies-literature
| S-SCDT-EMM-2020-12924 | biostudies-other
| S-EPMC3977247 | biostudies-literature
| S-EPMC3614472 | biostudies-literature
| S-EPMC7526443 | biostudies-literature
2017-02-18 | GSE93898 | GEO
| S-EPMC8649872 | biostudies-literature
| S-EPMC6708368 | biostudies-literature